Skip to main content

Exploring Novel Clinical Trial Designs for Gene-Based Therapies Proceedings of a Workshop (2020) / Chapter Skim
Currently Skimming:

Appendix C: Statement of Task
Pages 99-100

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 99...
... Speakers at the workshop may be asked to discuss patient recruitment and selection for gene-based clinical trials, assessing the safety of new therapies, dose escalation, and ethical issues such as informed consent and the role of clinicians in recommending trials as options to their patients. The concept of repeat dosing and sensitization treatments may also be explored.
Read the entire page →

Key Terms

  • clinical trials
  • patient recruitment
  • regulatory officials
  • planning committee
  • patient advocacy

  • informed consent
  • recommending trials
  • industry researchers
  • dose escalation
  • including academic

  • broad array
  • discuss patient
  • institutional policy
  • sensitization treatments
  • workshop agenda

  • designated rapporteur
  • repeat dosing
  • invite speakers


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.